Gladstone scientists identify single microRNA that controls blood vessel development

August 12, 2008

Provides potential therapeutic target for a number of diseases

Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs. The research, published in the latest issue of Developmental Cell, may offer clues to potential therapeutic targets for a wide variety of diseases, such as heart disease or cancer, that are impacted by or affect the vascular system.

Researchers in laboratory of GICD Director Deepak Srivastava, MD, found that microRNA (miR-126), a tiny RNA molecule, is intimately involved in the response of blood vessels to angiogenic signals. Angiogenesis, the process of vascular development, is a tightly regulated and well-studied process.A cascade of genes orchestrate a series of events leading to formation of blood vessels in an embryo.

"Some of these same gene regulatory networks are re-activated in the adult to direct the growth of new blood vessels" said Jason Fish, PhD, lead author of the study. "This can be beneficial, as in the case of a heart attack."

Blood vessel formation can also contribute to disease in settings like cancer, where vessels feed a growing tumor.

"Finding that a single factor regulates a large part of the angiogenic process creates a significant target for therapeutic development for any disease involving the vascular system," said Dr. Srivastava. "The next step is to find ways to modify this microRNA in the setting of disease and test its ability to alter the disease process."

Researchers examined cells, called endothelial cells, that line the lumen or inside of blood vessels. Once the vascular endothelial cells adopt their fate during development, they come together to form cord-like structures that are remodeled to become lumenized blood vessels. In adults, angiogenic signals, such as vascular endothelial growth factor (VEGF), activate endothelial cells and cause them to form new blood vessels. Individual microRNAs, which titrate the level of specific proteins generated by the cell, were not previously known to affect VEGF signaling or regulate angiogenesis.

The team used three model systems. First, they looked for microRNAs that were enriched in endothelial cells from mouse embryonic stem (ES) cells. They found that miR-126 was the most abundant in and most specific for endothelial cells. They next investigated the function of miR-126 in cultured human endothelial cells and found that this microRNA was involved in the structure, migration, proliferation and survival of endothelial cells. Third, they turned to the zebrafish system to investigate the in vivo function of miR-126 for three reasons. (1) It is a tractable system for perturbing microRNA levels and examining the consequences in a live organism. (2) The developing fish does not require a functioning cardiovascular system to survive through the initial stages of development. (3) The embryos are transparent and can be easily and directly visualized as they are developing. Loss of miR-126 function did not affect the initial patterning of the vascular network, but blood vessels subsequently collapsed and considerable internal bleeding occurred, illustrating the requirement of miR-126 for normal vessel formation and maintenance.

Researchers also found that miR-126 regulated endothelial responses to angiogenic signals by regulating several components of the VEGF pathway, which is important during development of blood vessels and is required for their maintenance. miR-126 repressed the actions of the Sprouty-related protein, SPRED1, and phosphoinositol-3 kinase regulatory subunit 2 both negative regulators of VEGF signals.

They replicated the effects of the loss of miR-126 by increasing expression of Spred1 or inhibiting VEGF signaling. Thus, miR-126 normally promotes vessel formation and stability by "repressing the repressors" of VEGF signaling. Since inhibiting VEGF signaling has been a major target of modern cancer therapies, regulating miR-126 represents an additional approach to regulate blood vessel formation in such diseases.

Gladstone Institutes

Pathophysiology and Clinical Applications of Nitric Oxide (Endothelial Cell Research)
by Gabor M. Rubanyi (Editor)

Research on the key mediator nitric oxide has increased exponentially over the last ten years. It is now clear that, in addition to its role within the cardiovascular system, this mediator is also implicated in the normal physiological function and disease pathology of several organs and systems. A number of the fundamental research observations are now being developed into therapeutic principles and these are being pursued through clinical trials. This is the first work summarizing, in its two volumes, the quantum leap from basic science to clinical applications emerging from this decade of research.

Endothelial Cells in Health and Disease
by William C. Aird (Editor)

This reference serves as the first source to gather current data from endothelial cell biologists in various disciplines to summarize recent progress in the field-providing a complete understanding of the endothelium in health and disease and demonstrating its potential as a therapeutic target.

Modern Visualisation of the Endothelium (Endothelial Cell Research Series)
by J M Polak (Author)

There can no longer be any doubt that the endothelium represents a very active tissue and is not, as had previously been thought, merely an inert lining material. On the contrary, the endothelium exerts a powerful influence on its environs through the release of multiple regulatory factors such as nitric oxide, endothelium derived hyperpolarizing factor and endothelin. It is therefore crucial to our understanding of the cardiovascular system that we are able to visualize the endothelial layer at the molecular level. Quantitative morphological studies permit visualization at this level, allowing the assessment of the changes that occur in the disease state. Modern methods of computerized image analysis have been applied to reconstruct the endothelial layer in three-dimensions - detecting...

Mechanical Forces and the Endothelium (Endothelial Cell Research Series)
by Peter Lelkes (Author), Michael A GimbroneJr (Author)

Initial multidisciplinary work provided an impressive descriptive fund of knowledge about the overall response of the endothelium to hemodynamic forces, and molecular biology has provided the tools for the discovery process to take a quantum leap forward in recent years. Each of these areas is addressed in detail in this volume, with gene regulation taking a central role. This book should be read by all those with an interest in vascular biology, including physiologists, biochemists, geneticists, and those interested in bioengineering and fluid dynamics.

Estrogen and the Vessel Wall (Endothelial Cell Research Series)
by Gabor M. Rubanyi (Editor), R Kauffman (Editor)

Estrogen and the Vessel Wall marks the start of a new era in understanding the cardiovascular actions of estrogen. It examines the hypothesis, derived from a growing body of epidemiological data, that estrogen acts directly upon the vessel wall to produce beneficial effects in the cardiovascular system.
Inspired by a satellite symposium of the IX International Vascular Biology Meeting, additional topics have been included, covered by leading experts. All subjects have been brought together here to produce an outstanding and integral publication, a milestone in the field of Vascular Research.

Vascular Protection: Molecular Mechanisms, Novel Therapeutic Principles and Clinical Applications (Endothelial Cell Research)
by Gabor M. Rubanyi (Author), Victor J. Dzau (Author), John P. Cooke (Author)

Vascular Protection explores advances in vascular biology and how they translate into innovations in drug therapy for vascular disease. It addresses recent advances in the knowledge of endothelial vasoactive factors and other biologically active molecules as well as gene therapy. Written by leading experts in their respective fields, each chapter emphasizes the mechanisms and pathologic consequences of vascular disorders, highlighting the clinical ramifications of these insights and the potential for new therapeutic strategies. Vascular Protection provides critical new information for researchers and clinicians, as well as to industrial scientists in pursuit of novel therapies for cardiovascular disorders.

Endothelial Modulation of Cardiac Function (Endothelial Cell Research)
by Malcolm J Lewis (Author), Ajay M Shah (Author)

Paracrine and autocrine regulation of cardiac function by "endothelial" mediators is becoming important both physiologically and pathophysiologically. This volume brings the researcher completely up to date with all aspects of endothelial regulation and cardiac function. Acknowledged experts in each field have contributed, making this work indispensable for researchers and of great interest to the clinical cardiologist.
The Endothelial Cell Research Series publishes significant reviews by experts in the field. The individual volumes provide invaluable guides to researchers studying endothelial cells and are effective reference texts for anyone working in the general areas of vascular biology and neurotransmission.
Endothelium was originally considered to be an inert lining for the...

Morphogenesis of Endothelium (Endothelial Cell Research Series)
by Werner Risau (Author), Gabor M. Rubanyi (Author)

The cardiovascular system is the first functional organ system to develop in the vertebrate embryo. Embryonic growth and differentiation essentially depend on transport of nutrients and waste through the early vasculature, and certain events in morphogenesis are thought to be influenced by the hemodynamic forces of the beating heart. The vasculature not only serves as a 'nutrient and waste pipeline' but is also a major communication system between distant organs and tissues. The vascular endothelial cell mediates vascular growth, permeability, integrity and interactions with blood cells. In most tissues the endothelium itself is highly specialized to meet the particular needs of the tissue in terms of quality and quantity of incoming and outgoing molecules and messages.
The areas...

Perspectives on Lung Endothelial Barrier Function, Volume 35 (Advances in Molecular and Cell Biology)
by C.E. Patterson (Author), Edward Bittar (Series Editor)

This readable, comprehensive text covers endothelial biology from the fundamentals of structure and lung fluid balance physiology to state-of-the-art descriptions of the molecular mechanisms involved in the development of lung failure. The material and illustrations, provided by outstanding experts in their individual areas of research and clinical concentration, is artfully woven together to provide the reader with an integrated, in-depth, and up-to-date knowledge of endothelial function, vascular integrity, pulmonary function, and pathophysiology in respiratory failure.

Footmarks of Innate Immunity in the Ovary and Cytokeratin-Positive Cells as Potential Dendritic Cells (Advances in Anatomy, Embryology and Cell Biology)
by Katharina Spanel-Borowski (Author)

The monograph introduces innate immunity as second authority in the ovary besides the endocrine system. Innate immunity appears to orchestrate follicular atresia, follicle rupture, follicle transformation into a corpus luteum (CL) and CL regression through nonsterile inflammation and tissue repair. The concept is new. It centres on cytokeratin-positive (CK+) cells being recognized as a potential nonlymphoid dendritic cell type (DC). Part I describes morphological aspects of immune privilege starting with active hamster ovary implants into the chicken chorioallantois membrane. Follicular atresia and follicle rupture correspond with mild and moderate tissue damage in ovaries of small rodents and rabbits. Superovulations cause severe tissue damage through intraovarian oocyte release with...